Optimizing the Use of Prophylaxis in Patients With Severe Haemophilia A

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2016

Primary Completion Date

April 9, 2021

Study Completion Date

April 9, 2021

Conditions

Hemophilia A

Interventions

DRUG

Oktokog alpha

adjusting dose and dose interval according to MyPKFIT

Trial Locations (1)

Malmö Centre for Thrombosis and Haemostasis, Malmo

All Listed Sponsors

lead

Lund University

OTHER

NCT03915080 - Optimizing the Use of Prophylaxis in Patients With Severe Haemophilia A | Biotech Hunter | Biotech Hunter